临床T1N0浸润性肺癌的选择性纵隔淋巴结清扫策略:一项前瞻性多中心临床试验
这项中国多中心前瞻性临床试验纳入720例外周型临床T1N0浸润性非小细胞肺癌患者,评估基于六项标准预测纵隔淋巴结阴性的选择性清扫策略。所有患者实际接受系统性纵隔淋巴结清扫,策略对所有预测为阴性的纵隔区域均正确预测。术中冰冻诊断LPA、VPI和肺门淋巴结转移的准确率分别为94.0%、98.9%和99.6%。
要点
- 策略在全部720例中正确预测了各纵隔区域的阴性淋巴结状态。
- 术中冰冻诊断LPA、VPI、肺门淋巴结转移准确率分别为94.0%、98.9%、99.6%。
- 术中诊断偏差未导致淋巴结阴性预测不准确。
核心结论
- 这是首个前瞻性验证cT1N0浸润性NSCLC特定纵隔淋巴结转移模式的研究,为选择性淋巴结清扫策略的临床应用提供重要证据。
研究设计与样本
- 中国多中心前瞻性临床试验,共纳入720例患者,所有患者实际接受系统性纵隔淋巴结清扫。
主要发现
- 清扫淋巴结中位数为15枚(四分位距11-20)。
- 策略正确预测了所有特定纵隔区域的阴性淋巴结状态。
- 与最终病理相比,冰冻切片诊断LPA、VPI和肺门淋巴结转移的准确率分别为94.0%、98.9%和99.6%。
- 术中LPA、VPI或肺门淋巴结转移诊断不准确未导致淋巴结阴性状态预测不准确。
关键数值与推荐
- 预测阴性淋巴结站的六项标准包括:实性成分占比≤0.5、肺段位置、贴壁为主型腺癌(LPA)、肺门淋巴结(10-12站)阴性、脏层胸膜侵犯(VPI)阴性。
- 上述指标单独或联合用于预测整个、上或下纵隔区域的淋巴结阴性状态。
- LPA、肺门淋巴结受累和VPI于术中诊断。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: We aimed to prospectively evaluate our previously proposed selective mediastinal lymph node (LN) dissection strategy for peripheral clinical T1N0 invasive NSCLC. METHODS: This is a multicenter, prospective clinical trial in China. We set six criteria for predicting negative LN stations and finally guiding selective LN dissection. Consolidation tumor ratio less than or equal to 0.5, segment location, lepidic-predominant adenocarcinoma (LPA), negative hilar nodes (stations 10-12), and negative visceral pleural invasion (VPI) were used separately or in combination as predictors of negative LN status in the whole, superior, or inferior mediastinal zone. LPA, hilar node involvement, and VPI were diagnosed intraoperatively. All patients actually underwent systematic mediastinal LN dissection. The primary end point was the accuracy of the strategy in predicting LN involvement. If LN metastasis occurred in certain mediastinal zone that was predicted to be negative, it was considered as an "inaccurate" case. RESULTS: A total of 720 patients were enrolled. The median number of LN dissected was 15 (interquartile range: 11-20). All negative node status in certain mediastinal zone was correctly predicted by the strategy. Compared with final pathologic findings, the accuracy of frozen section to diagnose LPA, VPI, and hilar node metastasis was 94.0%, 98.9%, and 99.6%, respectively. Inaccurate intraoperative diagnosis of LPA, VPI, or hilar node metastasis did not lead to inaccurate prediction of node-negative status. CONCLUSIONS: This is the first prospective trial validating the specific mediastinal LN metastasis pattern in cT1N0 invasive NSCLC, which provides important evidence for clinical applications of selective LN dissection strategy.
引用
- Zhang Y, Deng C, Zheng Q, et al. Selective Mediastinal Lymph Node Dissection Strategy for Clinical T1N0 Invasive Lung Cancer: A Prospective, Multicenter, Clinical Trial. J Thorac Oncol. 2023. PMID: 36841542. doi:10.1016/j.jtho.2023.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。